These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen. Jamet P, Ji B. Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):622. PubMed ID: 7868967 [No Abstract] [Full Text] [Related]
9. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens. Fajardo TT, Villahermosa L, Pardillo FE, Abalos RM, Burgos J, Dela Cruz E, Gelber RH. Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893 [Abstract] [Full Text] [Related]
10. Absence of relapse within 4 years among 34 multibacillary patients with high BIs treated for 2 years with MDT. Jesudasan K, Vijayakumaran P, Manimozhi N, Jeyarajan T, Rao PS. Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):133-5. PubMed ID: 8690971 [Abstract] [Full Text] [Related]
11. Implementation of multidrug therapy for leprosy control programmes. Porichha D. Lepr Rev; 1990 Dec; 61(4):392-3. PubMed ID: 2280664 [No Abstract] [Full Text] [Related]
12. Multidrug therapy in leprosy. WHO Study Group. Nurs J India; 1984 Apr; 75(4):83-6, 90. PubMed ID: 6565263 [No Abstract] [Full Text] [Related]
16. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. Jing Z, Zhang R, Zhou D, Chen J. Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621 [Abstract] [Full Text] [Related]